Research and Markets: Monoclonal Antibodies Market in Gastric and ... The Herald | HeraldOnline.com (press release) Gastric and esophageal cancers are two similar, overlapping groups of rare diseases, with their respective prevalence populations in the top eight markets estimated to be 392,000 and 169,000. However, their mortality rates are far higher than for other ... Monoclonal Antibodies Market in Gastric and Esophageal Cancers to Reach ... |
